Pulmonary thermal ablation in patients with prior pneumonectomy

American Journal of Roentgenology

Volumn 196, Issue 5, 2011, Pages

  Sofocleous, Constantinos T ^a   May, Benjamin ^a   Petre, Elena N ^a   Gonen, Mithat ^a   Thornton, Raymond H ^a   Alago, William ^a   Rizk, Nabil P ^a   Dupuy, Damian E ^b   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Ablation; Pneumonectomy

Indexed keywords

ABLATION THERAPY; ADULT; AGED; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER SIZE; CAUSE OF DEATH; CONTROLLED STUDY; DYSPNEA; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PULMONARY THERMAL ABLATION; RESPIRATORY DISTRESS; REVIEW; SAFETY; SURGICAL RISK; THORAX DRAINAGE; TREATMENT DURATION; ARTICLE; CARCINOMA; CATHETER ABLATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; INTERVENTIONAL RADIOLOGY; LUNG TUMOR; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CATHETER ABLATION; COHORT STUDIES; FEASIBILITY STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PNEUMONECTOMY; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959599716     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5154     Document Type: Review

References (24)

1. Gillams A. Lung tumour ablation: where are we now? Cancer Imaging 2008; 8:116-117 (Pubitemid 351722436)
2. McTaggart RA, Dupuy DE. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 2007; 10:102-113 (Pubitemid 350216511)
3. Spaggiari L, Grunenwald D, Girard P, Baldeyrou P. Completion right lower lobectomy for recurrence after pneumonectomy for metastases. Eur J Cardiothorac Surg 1997; 12:798-800 (Pubitemid 28035547)
4. Ambrogi MC, Fanucchi O, Lencioni R, Cioni R, Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax 2006; 61:828-829 (Pubitemid 44369410)
5. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006; 30:177-183 (Pubitemid 43850341)
6. de Baère T, Palussière J, Aupérin A, et al. Mid-term local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240:587-596
7. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007; 134:1306-1312 (Pubitemid 47633617)
8. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230:125-134 (Pubitemid 37549793)
9. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9:621-628
10. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intra-thoracic malignancies: a large single-center experience. Cancer 2007; 109:1397-1405 (Pubitemid 46466568)
11. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-275 (Pubitemid 46579719)
12. Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation: an international study survey. Anticancer Res 2004; 24:339-343 (Pubitemid 38279729)
13. Pua BB, Solomon SB. Radiofrequency ablation of primary and metastatic lung cancers. Semin Ultrasound CT MR 2009; 30:113-124
14. Pintilie M. Competing risks: a practical perspective. Chichester, UK: John Wiley & Sons Ltd., 2007
15. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004; 91:1229-1235 (Pubitemid 39424779)
16. Dignam JJ, Kocherginsky MN. Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 2008; 26:4027-4034
17. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995; 109:120-129
18. Grodzki T, Alchimowicz J, Kozak A, et al. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results. Eur J Cardiothorac Surg 2008; 34:493-498
19. Makimoto T, Tsuchiya S, Hayakawa K, Saitoh R, Mori M. Risk factors for severe radiation pneumonitis in lung cancer. Jpn J Clin Oncol 1999; 29:192-197
20. White DA, Stover DE. Severe bleomycin-induced pneumonitis: clinical features and response to corticosteroids. Chest 1984; 86:723-728 (Pubitemid 15217645)
21. Grieco CA, Simon CJ, Mayo-Smith WW, Dipetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol 2007; 30:361-367 (Pubitemid 47356680)
22. Donington JS, Miller DL, Rowland CC, et al. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg 2002; 74:154-158; discussion 158-159
23. Levasseur P, Regnard JF, Icard P, Dartevelle P. Cancer surgery on a single residual lung. Eur J Cardiothorac Surg 1992; 6:639-640; discussion 641
24. Terzi A, Lonardoni A, Scanagatta P, Pergher S, Bonadiman C, Calabro F. Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure. Eur J Cardiothorac Surg 2004; 25:456-459 (Pubitemid 38340587)